Seroprevalence of SARS-CoV-2 Antibodies and Factors Associated with Seropositivity at the University of Salamanca: The DIANCUSAL Study

被引:4
作者
Muro, Antonio [1 ]
Belhassen-Garcia, Moncef [1 ]
Munoz Bellido, Juan Luis [2 ,3 ,4 ]
Lorenzo Juanes, Helena [2 ,3 ,4 ]
Vicente, Belen [1 ]
Pendones, Josue [2 ,3 ,4 ]
Adserias, Jose [5 ]
Sanchez Hernandez, Gonzalo [6 ]
Rodriguez Rosa, Miguel [7 ]
Vicente Villardon, Jose Luis [7 ]
Burguillo, Javier [8 ]
Lopez Andaluz, Javier [9 ]
Martin Oterino, Jose Angel [2 ,10 ]
Garcia Criado, Francisco Javier [2 ]
Barbero, Fausto [9 ]
Morales, Ana Isabel [2 ,11 ]
Galindo Villardon, Purificacion
Gonzalez Sarmiento, Rogelio [2 ,12 ]
机构
[1] Univ Salamanca, Infect & Trop Dis Grp e INTRO, Inst Biomed Res Salamanca Res Ctr Trop Dis Un, Fac Pharm, Salamanca 37008, Spain
[2] Univ Salamanca, Inst Biomed Res Salamanca IBSAL, Univ Hosp Salamanca, Salamanca 37007, Spain
[3] Univ Hosp Salamanca, Microbiol & Parasitol Serv, Salamanca 37007, Spain
[4] Univ Salamanca, Dept Biomed & Diagnost Sci, Salamanca 37008, Spain
[5] Univ Salamanca, Univ Salamanca Fdn FGUSAL, IT Dept, Salamanca 37008, Spain
[6] Univ Salamanca, Data Proc Ctr CPD, Salamanca 37008, Spain
[7] Univ Salamanca, Dept Stat, Salamanca 37008, Spain
[8] Univ Salamanca, Fac Pharm, Dept Chem Phys, Salamanca 37008, Spain
[9] Univ Salamanca, Dept Nursing & Phisiotherapy, Salamanca 37008, Spain
[10] Univ Hosp Salamanca, Dept Internal Med, Fac Med, Salamanca 37008, Spain
[11] Univ Salamanca, Toxicol Unit, Salamanca 37008, Spain
[12] Univ Salamanca, Dept Med, Mol Med Unit, Salamanca 37008, Spain
关键词
SARS-CoV-2; COVID-19; antibodies; seroprevalence; screening; university; Salamanca; Spain;
D O I
10.3390/jcm10153214
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Systematic screening for antibodies against SARS-CoV-2 is a crucial tool for surveillance of the COVID-19 pandemic. The University of Salamanca (USAL) in Spain designed a project called "DIANCUSAL" (Diagnosis of New Coronavirus, COVID-19, in University of Salamanca) to measure antibodies against SARS-CoV-2 among its similar to 34,000 students and academic staff, as the influence of the university community in the spread of the SARS-CoV-2 pandemic in the city of Salamanca and neighboring towns hosting USAL campuses could be substantial. Objective: The aim of this study was to estimate the prevalence of SARS-CoV-2 antibodies among USAL students, professors and staff and to evaluate the demographic, academic, clinical and lifestyle and behavioral factors related to seropositivity. Methodology: The DIANCUSAL study is an ongoing university population-based cross-sectional study, with the work described herein conducted from July-October 2020. All USAL students, professors and staff were invited to complete an anonymized questionnaire. Seroprevalence of anti-SARS-CoV-2 antibodies was detected and quantified by using chemiluminescent assays for IgG and IgM. Principal findings: A total of 8197 (24.71%) participants were included. The mean age was 31.4 (14.5 SD) years, and 66.0% of the participants were female. The seroprevalence was 8.25% overall and was highest for students from the education campus (12.5%) and professors from the biomedical campus (12.6%), with significant differences among faculties (p = 0.006). Based on the questionnaire, loss of smell and fever were the symptoms most strongly associated with seropositivity, and 22.6% of seropositive participants were asymptomatic. Social distancing was the most effective hygiene measure (p = 0.0007). There were significant differences in seroprevalence between participants with and without household exposure to SARS-CoV-2 (p = 0.0000), but not between students who lived in private homes and those who lived in dormitories. IgG antibodies decreased over time in the participants with confirmed self-reported COVID-19 diagnoses. Conclusions: The analysis revealed an overall 8.25% seroprevalence at the end of October 2020, with a higher seroprevalence in students than in staff. Thus, there is no need for tailored measures for the USAL community as the official average seroprevalence in the area was similar (7.8% at 22 June and 12.4 at 15 November of 2020). Instead, USAL members should comply with public health measures.
引用
收藏
页数:16
相关论文
共 50 条
[21]   Silent SARS-CoV-2 infection: seroprevalence study of SARS-CoV-2 anti- nucleocapsid IgG antibodies in Kragujevac, Serbia [J].
Cicaric, Neda ;
Canovic, Vanja ;
Stojkovic, Milica ;
Matic, Sanja ;
Stefanovic, Srdjan ;
Popovic, Suzana ;
Todorovic, Danijela ;
Djordjevic, Natasa ;
Radenkovic, Biljana ;
Radenkovic, Marko ;
Antic, Vasilije ;
Baskic, Dejan .
ACTA VIROLOGICA, 2023, 67
[22]   A Cross-Sectional Study of SARS-CoV-2 Antibodies and Risk Factors for Seropositivity in Staff in Day Care Facilities and Preschools in Denmark [J].
Fogh, Kamille ;
Eriksen, Alexandra R. R. ;
Larsen, Tine Graakjaer ;
Hasselbalch, Rasmus B. ;
Bundgaard, Henning ;
Scharff, Bibi F. S. S. ;
Nielsen, Susanne D. ;
Jorgensen, Charlotte S. ;
Erikstrup, Christian ;
ostergaard, Lars ;
Ellermann-Eriksen, Svend ;
Andersen, Berit ;
Nielsen, Henrik ;
Johansen, Isik S. ;
Wiese, Lothar ;
Hindhede, Lotte ;
Mikkelsen, Susan ;
Saekmose, Susanne G. ;
Aagaard, Bitten ;
Holm, Dorte K. ;
Harritshoj, Lene ;
Simonsen, Lone ;
Fischer, Thea K. ;
Folke, Fredrik ;
Lippert, Freddy ;
Ostrowski, Sisse R. ;
Benfield, Thomas ;
Molbak, Kare ;
Ethelberg, Steen ;
Koch, Anders ;
Vangsted, Anne-Marie ;
Krause, Tyra Grove ;
Fomsgaard, Anders ;
Ullum, Henrik ;
Skov, Robert ;
Iversen, Kasper .
MICROBIOLOGY SPECTRUM, 2023, 11 (01)
[23]   Seroprevalence of SARS-CoV-2 antibodies in South Korea [J].
Lee, Kwangmin ;
Jo, Seongil ;
Lee, Jaeyong .
JOURNAL OF THE KOREAN STATISTICAL SOCIETY, 2021, 50 (03) :891-904
[24]   Seroprevalence of SARS-CoV-2 antibodies in South Korea [J].
Kwangmin Lee ;
Seongil Jo ;
Jaeyong Lee .
Journal of the Korean Statistical Society, 2021, 50 :891-904
[25]   Estimation of world seroprevalence of SARS-CoV-2 antibodies [J].
Lee, Kwangmin ;
Kim, Seongmin ;
Jo, Seongil ;
Lee, Jaeyong .
JOURNAL OF APPLIED STATISTICS, 2024, 51 (15) :3039-3058
[26]   Bayesian estimation of the seroprevalence of antibodies to SARS-CoV-2 [J].
Dong, Qunfeng ;
Gao, Xiang .
JAMIA OPEN, 2020, 3 (04) :496-499
[27]   SARS-CoV-2 seroprevalence and associated risk factors in periurban Zambia: a population-based study [J].
Shanaube, K. ;
Schaap, A. ;
Klinkenberg, E. ;
Floyd, S. ;
Bwalya, J. ;
Cheeba, M. ;
de Haas, P. ;
Kosloff, B. ;
Ruperez, M. ;
Hayes, R. ;
Ayles, H. .
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2022, 118 :256-263
[28]   Seroprevalence of SARS-CoV-2 antibodies in the county town of Slovakia - a pilot study from the Trencin city [J].
Kajanova, Ivana ;
Grossmannova, Katarina ;
Jelenska, Lenka ;
Lukacikova, Lubomira ;
Radikova, Zofia ;
Knutova, Nikola ;
Nahlikova, Jana ;
Belisova, Martina ;
Pastorekova, Silvia ;
Kopacek, Juraj .
ACTA VIROLOGICA, 2022, 66 (03) :228-237
[29]   Seroprevalence of SARS-CoV-2 antibodies among rural healthcare workers [J].
Neises, Jordan Z. ;
Hossain, Md. Saddam ;
Sultana, Rifat ;
Wanniarachchi, Kevin N. ;
Wollman, Jared W. ;
Nelson, Eric ;
Specker, Bonny L. ;
Hoppe, Adam D. ;
Lawson, Steven R. ;
Thiex, Natalie W. .
JOURNAL OF MEDICAL VIROLOGY, 2021, 93 (12) :6611-6618
[30]   The Seroprevalence of SARS-CoV-2 Antibodies among HealthCareWorkers in University Hospital in Krakow before the Era of Vaccination [J].
Zoltowska, Barbara ;
Baranska, Ilona ;
Jachowicz, Estera ;
Sydor, Wojciech ;
Maziarz, Barbara ;
Mydel, Krzysztof ;
Rozanska, Anna ;
Wizner, Barbara ;
Rosinski, Jerzy ;
Kossowska, Magdalena ;
Glomb, Kaja ;
Wojkowska-Mach, Jadwiga .
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2022, 19 (07)